It hasn't been the best quarter for Texas Instruments Incorporated ( NASDAQ:TXN ) shareholders, since the share ...

Americans uniformly believe that workers deserve a basic standard of living free from employer exploitation. All states and ...

Avadel Pharmaceuticals (AVDL) is undervalued, with $2B+ sales potential and key catalysts ahead. Read here for more analysis.

The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you ...

In this continuation of a three-part series, the author explores the potential use of agentic AI in pharmaceutical R&D.

When we invest, we're generally looking for stocks that outperform the market average. Buying under-rated businesses ...

Baron Durable Advantage Fund had a strong second quarter of 2025, outperforming its benchmark, the S&P 500 Index. Read more ...

In a post on X, MSE highlighted: "Are you one of eight million people due a share of £25 BILLION of unclaimed benefits? Don't ...

Researchers at Baylor College of Medicine have developed a powerful new data analysis method named COOKIE-Pro (Covalent ...

After a difficult period for CSL Ltd (ASX: CSL) shares, it’s important to ask whether the ASX healthcare share is a buy.

From Grave of the Fireflies and Children of Heaven to Little Women, here are some of the highest-rated movies about siblings.

The clinical-stage biopharmaceutical company revealed that regulators advised against proceeding with a BLA submission following results from its IOB-013 trial, where Cylembio plus pembrolizumab ...